Genetically engineered cell lines used in biomedical research have long been prone to misidentification and unauthorized use, wasting billions of dollars each year and jeopardizing critical scientific discoveries. These problems not only undermine reproducibility of research results, but also put valuable intellectual property at risk.

Now, researchers at The University of Texas at Dallas have developed a novel method to embed unique genetic identifiers in engineered cell lines, eliminating identification errors and safeguarding innovations with tamper-proof genomic tags.

The team of Riccardo Levato at UMC Utrecht and Utrecht University is now taking an important step toward printing implantable tissues. Using computer vision, a branch of artificial intelligence (AI), they’ve developed a 3D printer that doesn’t just print, it also sees and even co-designs. Their innovation was published today in Nature. With this innovation, they tackle one of the biggest challenges in 3D bioprinting: improving both the survival and functionality of cells in printed living tissue. But how exactly does that work?

Weill Cornell Graduate School of Medical Sciences doctoral student Ana Campos Codo has been selected for the 2025 cohort of the Gilliam Fellows Program by Howard Hughes Medical Institute (HHMI).